FDA to Ask Experts About Avandia Risk

The Food and Drug Administration will ask outside experts next week whether the diabetes drug Avandia should carry label warnings of heart attack risk.

Another Risk Factor for Merck

Plaintiffs' lawyers are salivating over evidence they hope could support their argument that even patients who used the painkiller for short periods were in danger.

Patient Prescribed Avandia was Heart Attack Waiting to Happen

Up until this past month, I had no idea that Avandia had anything to do with my heart problem. A friend saw something on TV about Avandia and its link to heart attacks.

Did Merck Hide the Risks of Fosamax

Merck, maker of osteoporosis drug Fosamax, may have "seriously underreported" risks of jawbone death related to the drug, according to the American Association of Oral and Maxillofacial Surgeons.

Vioxx Heart Problems Start Early, Study Finds

The heart problems associated with the painkiller Vioxx increase soon after beginning treatment, says a new study published in the New England Journal of Medicine.

Governors Subpoenaed for Vioxx Cases

Govs. Haley Barbour of Mississippi and Mitch Daniels of Indiana have been subpoenaed by lawyers for people who blame their heart attacks or those of family members on the once-popular painkiller Vioxx.

Pollution Cleanup Costs Cloud 3M Stock Outlook

The recent run-up in 3M stock could be validated by earnings to be reported, but pollution costs are likely to get new scrutiny.

Prempro Lawsuit Settled Hours Before Trial Set to Begin

The biggest maker of birth control pills in the United States, Wyeth, settled a lawsuit on the eve of a trial for a terminally ill woman who blamed the company's Prempro menopause drug for her breast cancer.

Breast-Cancer Rate Follows Drop in Hormone Therapy

Breast-cancer rates among Northwest women have plummeted since 2002, when thousands abruptly quit taking hormone-replacement medicines, a large new study shows.

Merck sets Aside $810 Million for Vioxx Lawsuits

Merck & Co., the third-largest U.S. drugmaker, said it has set aside $810 million to cover costs stemming from lawsuits by customers claiming injuries from using the company's Vioxx painkiller.